A research filter, not a predictor — not financial advice. Grades rank growth stocks on evidence-based quality signals from end-of-day data; they are not buy/sell calls or price forecasts. Always do your own research.
Glaukos Corporation GKOS
Mixed broader-coverage candidate · Glaukos Corporation operates as an ophthalmic medical technology and pharmaceutical enterprise, primarily focused on pioneering novel therapies for glaucoma, corneal disorders, and retinal diseases.
On FrontierLab's discovery record since 2026-07-30 (3 weeks ago) — when this name first surfaced. (distinct from the snapshot date below)
Auto-graded broader coverage — sourced by an automated screen and graded on default bands, not the sector-calibrated bands the curated screener uses. A "Mixed" here is NOT the same bar as a curated grade; these are auto-screened candidates for your own research, shown as of their surface date (2026-07-31), not the curated Frontier signal.
Key quality signals
| Revenue growth (YoY) | 41.5% |
|---|---|
| Gross margin | 79.1% |
| Gross profits / assets | 0.53 |
| Rule of 40 | 28.4 |
| Net margin | -13.1% |
| Cash runway (months) | 120 |
| PEG | — |
| Price / sales | 16.2 |
Quality checklist
- ~ Revenue growth — 41.5% (pass ≥ 20%)
- ✓ Gross profits / assets — 0.53 (pass ≥ 0.33)
- ✓ Gross margin — 79.1% (pass ≥ 60%)
- ~ Cash generation
- ~ Share dilution — 2.1%
Fundamentals — snapshot as of 2026-07-31
| Stage | Established |
|---|---|
| Share issuance (YoY) | 2.1% · modest issuance |
| Moat | — |
| TAM | — |
| P/E (trailing) | — |
| EPS (trailing) | $-3.25 |
| Burn multiple | — |
| Gross-margin trend (pts) | 2.8 |
| Cash / assets | 0.31 |
| Net debt / EBITDA | — |
| Statements as of | Q2 FY2026 · filed 2026-07-29 |
Momentum context — a snapshot from 2026-07-31, not current
| Price at surface | $168.52 (as of 2026-07-31) |
|---|---|
| 52-week range | $73.16 – $183.57 |
| % off 52-wk high | -8.2% |
| RSI (14) | 75 |
| Relative volume | 2.9× |
Risk flags
← All broader-coverage names · Curated names → · Open the interactive screener →
Data as of 2026-07-31 (end-of-day). How grades are computed →